Source: Business Wire

Press Release: BostonGene : BostonGene Named a Fierce Life Sciences Innovation Awards Winner in the AI Innovation Category

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading provider of artificial intelligence (AI)-driven molecular and immune profiling solutions, today announces it was named a Fierce Life Sciences Innovation Awards winner by Fierce Biotech and Fierce Pharma in the AI innovation category. The program showcases outstanding solutions that are driving improvements and transforming the industry. BostonGene's award-winning innovation addresses critical challenges in pathology. Traditional pathology r

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Andrew Feinberg's photo - President & CEO of BostonGene

President & CEO

Andrew Feinberg

CEO Approval Rating

84/100

Read more